Cargando…
The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease
BACKGROUND: Although major guidelines uniformly recommend iron supplementation and erythropoietin stimulating agents (ESAs) for managing chronic anemia in persons with chronic kidney disease (CKD), there are differences in the recommended hemoglobin (Hb) treatment target and no guidelines consider t...
Autores principales: | Yarnoff, Benjamin O., Hoerger, Thomas J., Simpson, Siobhan A., Pavkov, Meda E., Burrows, Nilka R., Shrestha, Sundar S., Williams, Desmond E., Zhuo, Xiaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942058/ https://www.ncbi.nlm.nih.gov/pubmed/27404556 http://dx.doi.org/10.1371/journal.pone.0157323 |
Ejemplares similares
-
The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
por: Yarnoff, Benjamin O., et al.
Publicado: (2017) -
Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC study
por: Yarnoff, Benjamin O., et al.
Publicado: (2018) -
Reported Cases of End-Stage Kidney Disease — United States, 2000–2019
por: Burrows, Nilka Ríos, et al.
Publicado: (2022) -
Trends in Hospitalizations for Acute Kidney Injury — United States, 2000–2014
por: Pavkov, Meda E., et al.
Publicado: (2018) -
Long-term mortality among kidney transplant recipients with and without diabetes: a nationwide cohort study in the USA
por: Harding, Jessica L, et al.
Publicado: (2021)